Investigación

Enfermedades Infecciosas y Microbioma

Buscador de publicaciones

Publicaciones

  • de Aranzabal M, Fumadó V, Alegria I, Rivera M, Torre N, Guibert B, Muñoz MJ, Moraleda C and Bassat Q.

    COVID-19 and Africa: Surviving between a rock and a hard place

    ANALES DE PEDIATRIA . 93(6): .

    [doi:10.1016/j.anpedi.2020.07.007]

  • Noguera-Julián A, Calzada-HernÁndez J, Brinkmann F, Basu Roy R, Bilogortseva O, Buettcher M, Carvalho I, Chechenyeva V, Falcon L, Goetzinger F, Guerrero-Laleona C, Hoffmann P, Jelusic M, Niehues T, Ozere I, Shackley F, Suciliene E, Welch SB, SchÖLvinck EH, Ritz N and Tebruegge M.

    Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-alpha Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study

    CLINICAL INFECTIOUS DISEASES . 71(10): 2561-2569. Nº de citas: 21

    [doi:10.1093/cid/ciz1138]

  • Wolf J, Kalocsai K, Fortuny-Guasch C, Lazar S, Bosis S, Korczowski B, Petit A, Bradford D, Croos-Dabrera R, Incera E, Melis J and van Maanen R.

    Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE)

    CLINICAL INFECTIOUS DISEASES . 71(10): 2581-2588. Nº de citas: 50

    [doi:10.1093/cid/ciz1149]

  • Núñez Cuadros E, Calvo Rey C, Saavedra-Lozano J, Acobendas Rueda R, Clemente Garulo D, Sanz Santaeufemia FJ, Martínez Campos L, Tarragó García A, García-Fontecha CG, Melendo Pérez S, Camacho Lovillo M, Falcón Neyra L, Fumadó V, Cerdeira Barreiro N and García Martín A.

    Evaluación del impacto del Documento de Consenso español sobre el abordaje de las infecciones osteoarticulares en nuestro medio a través de la Red de Infecciones Osteoarticulares Pediátricas (RIOPed)

    ANALES DE PEDIATRIA . 93(5): 289-296.

  • Garcia-Garcia S, Pérez-Argüello A, Henares-Bonilla D, Timoneda N and Munoz-Almagro C.

    Rapid identification, capsular typing and molecular characterization of Streptococcus pneumoniae by using whole genome nanopore sequencing

    BMC MICROBIOLOGY . 20(1): 347-347. Nº de citas: 11

    [doi:10.1186/s12866-020-02032-x]

  • Izquierdo C, Ciruela P, Hernández S, García-García JJ, Esteva-Afonso C, Moraga-Llop F, Álvaro Díaz Conradi, Johanna Martínez Osorio, Solé-Ribalta A, MARIA FERNANDEZ DE SEVILLA ESTRACH, González-Peris S, Codina G, Planes AM, Uriona S, Campins M, Munoz-Almagro C, Salleras L and Domínguez A.

    Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era

    EPIDEMIOLOGY AND INFECTION . 148: 1-37. Nº de citas: 8

    [doi:10.1017/S0950268820002708]

  • Alvarez J, Godoy P, Plans-Rubio P, Camps N, Carol M, Carmona G, Solano R, Rius C, Minguell S, Barrabeig I, Sala-Farré MR, Rodriguez R, Garcia-Cenoz M, Munoz-Almagro C and Dominguez A.

    Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013

    EMERGING INFECTIOUS DISEASES . 26(11): 2678-2684. Nº de citas: 4

    [doi:10.3201/eid2611.181418]

  • Alcalá Minagorre PJ, Villalobos Pinto E, Ramos Fernández JM, Rodríguez-Fernández R, Vázquez Ronco M, Escosa-García L, Montiano Jorge JI and García-García JJ.

    Changes from COVID-19. A perspective from internal pediatric medicine

    ANALES DE PEDIATRIA . 93(5): . Nº de citas: 4

    [doi:10.1016/j.anpedi.2020.06.004]

  • Molero M, Casas-Alba D, Orellana G, Ormazabal-Herrero A, Sierra-March C, Oliva C, Valls-Lafon A, Velasco J, Launes-Montana C, Cuadras-Palleja D, Pérez-Dueñas B, Jordán-García I, Cambra-Lasaosa FJ, Ortigoza-Escobar JD, Munoz-Almagro C, Garcia-Cazorla A, Armangue-Salvador T and Artuch-Iriberri R.

    Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases

    SCIENTIFIC REPORTS . 10(1): 18291-18291. Nº de citas: 32

    [doi:10.1038/s41598-020-75500-z]

  • Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL, HGID Lab, NIAID-USUHS Immune Response to COVID Group, COVID Clinicians, COVID-STORM Clinicians, Imagine COVID Group, French COVID Cohort Study Group, Milieu Intérieur Consortium, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank and COVID Human Genetic Effort.

    Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    SCIENCE . 370(6515): 423. Nº de citas: 1749

    [doi:10.1126/science.abd4585]